Effects of pre-analytical processes on blood samples used in metabolomics studies

Abstract

Every day, analytical and bio-analytical chemists make sustained efforts to improve the sensitivity, specificity, robustness, and reproducibility of their methods. Especially in targeted and non-targeted profiling approaches, including metabolomics analysis, these objectives are not easy to achieve; however, robust and reproducible measurements and low coefficients of variation (CV) are crucial for successful metabolomics approaches. Nevertheless, all efforts from the analysts are in vain if the sample quality is poor, i.e. if preanalytical errors are made by the partner during sample collection. Preanalytical risks and errors are more common than expected, even when standard operating procedures (SOP) are used. This risk is particularly high in clinical studies, and poor sample quality may heavily bias the CV of the final analytical results, leading to disappointing outcomes of the study and consequently, although unjustified, to critical questions about the analytical performance of the approach from the partner who provided the samples. This review focuses on the preanalytical phase of liquid chromatography–mass spectrometry-driven metabolomics analysis of body fluids. Several important preanalytical factors that may seriously affect the profile of the investigated metabolome in body fluids, including factors before sample collection, blood drawing, subsequent handling of the whole blood (transportation), processing of plasma and serum, and inadequate conditions for sample storage, will be discussed. In addition, a detailed description of latent effects on the stability of the blood metabolome and a suggestion for a practical procedure to circumvent risks in the preanalytical phase will be given.Graphical AbstractThe procedures and potential problems in preanalytical aspects of metabolomics studies using blood samples. Bias in the preanalytical phase may lead to unwanted results in the subsequential studies

Pre-Analytical Factors Influence Vitamin D Measurement In Clinical Laboratory

“…The available choices of these tubes used are; two different plasma anticoagulant tubes containing either (heparin or EDTA), red top serum tubes or gel tubes. Concerns have been raised regarding using serum or plasma which may affect the concentration of vitamin D measurements [40]. Although there was a little information about the potential impact of blood collection tubes on vitamin D concentrations, conflicted results were reported by two different studies.…”

LC–MS based global metabolite profiling: the necessity of high data quality

“…Sample collection, sample storage and sample handling are important steps to consider when attempting to generate a biologically relevant hypothesis (Jørgenrud et al 2015;Yin et al 2015) and are thus also relevant in regards to data quality. Briefly, blood-based samples require specific care as it, compared to other biofluids (e.g.…”

An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry

“…SELDI-TOF-MS proteomic profiling has been proposed as a promising high-throughput technology with potential applications in BC screening, detection and prognostication. In some studies, detected ion peaks were identified as different due to variations in population demographics, stage of disease, collection and storage conditions of samples, and analytical procedures (11,32,33). Aside from the most common proteins (BC1, BC2, BC3 and CA15-3), many of the studied peaks had poor sensitivities and specificities and alone were insufficient to diagnose BC.…”